{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:26:31Z","timestamp":1788647191753,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Center for Global Health and Medicine COVID-19 Gift Fund","award":["19K059"],"award-info":[{"award-number":["19K059"]}]},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau Research Fund","doi-asserted-by":"publisher","award":["2020-B-09"],"award-info":[{"award-number":["2020-B-09"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau Research Fund","doi-asserted-by":"publisher","award":["2024-B-01"],"award-info":[{"award-number":["2024-B-01"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["21A2013D"],"award-info":[{"award-number":["21A2013D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["23A2020D"],"award-info":[{"award-number":["23A2020D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["24A1011"],"award-info":[{"award-number":["24A1011"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>After the prolonged coronavirus disease 2019 pandemic, during which the seasonal influenza epidemic was suppressed, Japan experienced a record-breaking influenza A\/H1N1 outbreak in the 2024\u20132025 season. This situation also raises a concern about the immunogenicity of the annual inactivated influenza vaccine. This study evaluated postvaccination hemagglutination inhibition (HI) antibody titers and their association with influenza infection risk among healthcare workers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A serosurvey was conducted among staff at a national medical and research center in Tokyo in December 2024, 1 month after staff received the inactivated influenza vaccine. HI antibody titers against vaccine strains were measured, and participants were followed for influenza infection until January 2025. Seroprotection was defined as an HI titer \u226540. A Cox proportional hazards model assessed the association between HI titers and infection risk among vaccinated participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1507 vaccinated participants, only 12.7% had seroprotective HI titers against A\/H1N1. Around 90% had no influenza history for at least 4 seasons and had received repeated vaccinations over 2 seasons. Participants with HI titers &amp;lt;40 had a 4-fold higher infection risk than those with titers \u226540. A dose-response association was observed, even within the range below the titer of 40. Relative to titers &amp;lt;10, titers of 10 and 20 conferred 47.3% and 57.9% protection, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After a prolonged period without a major influenza epidemic, HI titers against A\/H1N1 were extremely low in vaccinated healthcare workers. Nonetheless, higher postvaccination HI titers, even at relatively low levels, were associated with protection, supporting the benefit of vaccines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf183","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:29:49Z","timestamp":1744183789000},"page":"727-734","source":"Crossref","is-referenced-by-count":2,"title":["Low Levels of Postvaccination Hemagglutination Inhibition Antibodies and Their Correlation With Influenza Protection Among Healthcare Workers During the 2024\u20132025 A\/H1N1 Outbreak in Japan"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-8577","authenticated-orcid":false,"given":"Shohei","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1198-2228","authenticated-orcid":false,"given":"Tetsuya","family":"Mizoue","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8150-075X","authenticated-orcid":false,"given":"Mugen","family":"Ujiie","sequence":"additional","affiliation":[{"name":"Vaccination Support Center, Disease Control and Prevention Center, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Horii","sequence":"additional","affiliation":[{"name":"Infection Control Office, National Center for Global Health and Medicine, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko S","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-8970","authenticated-orcid":false,"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, Japan Institute for Health Security , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2025092306164845800_jiaf183-B1","author":"National Institute of Infection Diseases","year":"2025"},{"key":"2025092306164845800_jiaf183-B2","author":"Tokyo Metropolitan Infectious Disease Surveillance Center","year":"2024"},{"key":"2025092306164845800_jiaf183-B3","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"key":"2025092306164845800_jiaf183-B4","doi-asserted-by":"crossref","first-page":"612747","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize prime\/boost vaccine strategies: trained immunity as a new player in the game","volume":"12","author":"Palgen","year":"2021","journal-title":"Front Immunol"},{"key":"2025092306164845800_jiaf183-B5","doi-asserted-by":"crossref","first-page":"1201.e1","DOI":"10.1016\/j.cmi.2023.05.020","article-title":"Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine","volume":"29","author":"Yamamoto","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025092306164845800_jiaf183-B6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/infdis\/jiad317","article-title":"Preinfection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis","volume":"228","author":"Yamamoto","year":"2023","journal-title":"J Infect Dis"},{"key":"2025092306164845800_jiaf183-B7","volume-title":"WHO manual on animal influenza diagnosis and surveillance","author":"World Health Organization","year":"2002"},{"key":"2025092306164845800_jiaf183-B8","author":"National Institute of Infectious Diseases","year":"2025"},{"key":"2025092306164845800_jiaf183-B9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"Epidemiol Infect"},{"key":"2025092306164845800_jiaf183-B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coisb.2018.08.011","article-title":"Influenza\u2014a new pathogen every year","volume":"12","author":"Abreu","year":"2018","journal-title":"Curr Opin Syst Biol"},{"key":"2025092306164845800_jiaf183-B11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-024-01889-5","article-title":"B cell memory: from generation to reactivation: a multipronged defense wall against pathogens","volume":"10","author":"Syeda","year":"2024","journal-title":"Cell Death Discov"},{"key":"2025092306164845800_jiaf183-B12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jit207","article-title":"Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets","volume":"208","author":"Cheng","year":"2013","journal-title":"J Infect Dis"},{"key":"2025092306164845800_jiaf183-B13","doi-asserted-by":"crossref","first-page":"e132155","DOI":"10.1172\/jci.insight.132155","article-title":"Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination","volume":"5","author":"Abreu","year":"2020","journal-title":"JCI Insight"},{"key":"2025092306164845800_jiaf183-B14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2025092306164845800_jiaf183-B15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.vaccine.2015.10.119","article-title":"Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to A\/Perth\/16\/2009 (H3N2)\u2013like virus during 2010\u201311","volume":"34","author":"Thompson","year":"2016","journal-title":"Vaccine"},{"key":"2025092306164845800_jiaf183-B16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/infdis\/jiz327","article-title":"The effect of influenza vaccination history on changes in hemagglutination inhibition titers after receipt of the 2015\u20132016 influenza vaccine in older adults in Hong Kong","volume":"221","author":"Ng","year":"2020","journal-title":"J Infect Dis"},{"key":"2025092306164845800_jiaf183-B17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-2600(22)00266-1","article-title":"Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis","volume":"11","author":"Jones-Gray","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025092306164845800_jiaf183-B18","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025092306164845800_jiaf183-B19","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/cix209","article-title":"Repeated vaccination does not appear to impact upon influenza vaccine effectiveness against hospitalization with confirmed influenza","volume":"64","author":"Cheng","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025092306164845800_jiaf183-B20","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1016\/j.vaccine.2017.06.088","article-title":"Repeated seasonal influenza vaccination among elderly in Europe: effects on laboratory confirmed hospitalised influenza","volume":"35","author":"Rondy","year":"2017","journal-title":"Vaccine"},{"key":"2025092306164845800_jiaf183-B21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/CIA.S238786","article-title":"A population-based propensity score\u2013matched study to assess the impact of repeated vaccination on vaccine effectiveness for influenza-associated hospitalization among the elderly","volume":"15","author":"Hsu","year":"2020","journal-title":"Clin Interv Aging"},{"key":"2025092306164845800_jiaf183-B22","author":"National Institute of Infectious Diseases"},{"key":"2025092306164845800_jiaf183-B23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"2025092306164845800_jiaf183-B24","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1186\/s12889-021-12175-9","article-title":"Global trends and predictors of face mask usage during the COVID-19 pandemic","volume":"21","author":"Badillo-Goicoechea","year":"2021","journal-title":"BMC Public Health"},{"key":"2025092306164845800_jiaf183-B25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf183\/62907065\/jiaf183.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/727\/62907065\/jiaf183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/727\/62907065\/jiaf183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:19:12Z","timestamp":1758622752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/3\/727\/8110526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4,10]]},"published-print":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf183","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.06.25321776","asserted-by":"object"}]},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,15]]},"published":{"date-parts":[[2025,4,10]]}}}